Dr. Shuangxi Li 李双喜
Chief Physician
Gastrointestinal Tumor Center, Ward 1, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, minimally invasive, and comprehensive treatment of gastrointestinal tumors, including preoperative chemotherapy, radiochemotherapy, and intraperitoneal hyperthermic perfusion chemotherapy. Diagnosis and treatment of rare GI tumors such as stromal tumors and neuroendocrine tumors.
Dr. Li holds a bachelor’s from Peking University Health Science Center, a master’s in general surgery from Peking University First Hospital, and a doctorate in GI surgical oncology from Peking University Cancer Institute. Trained under Professor Ji Jiafu, Dr. Li completed visiting studies in gastric surgery at Yonsei University under Professor Noh Sung Hoon and visited centers in Japan, Korea, and Italy.
Name order: in Chinese the family name comes first (Li Shuangxi). Papers usually list the name as Shuangxi Li or Li S.
Selected publications
61 papers on PubMed matched by name and affiliation; 3 as first or senior author since 2016. Most recent first- or senior-author papers:
- Chin J Cancer Res, 2022 (first author): Laparoscopic vs. open lower mediastinal lymphadenectomy for Siewert type II/III adenocarcinoma of esophagogastric junction: An exploratory, observational, prospective, IDEAL stage 2b cohort study (CLASS-10 study). PubMed 36199536
- Int J Clin Oncol, 2021 (first author): The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database. PubMed 33788042
- BMC Cancer, 2016 (first author): Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy. PubMed 26786480
- Zhonghua Wei Chang Wai Ke Za Zhi, 2013 (first author): [Application of perioperative imatinib mesylate therapy in initial resectable primary local advanced gastrointestinal stromal tumor at intermediate or high risk]. PubMed 23536340
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion